The polymorphism disparity of cytomegalovirus UL97 gene in pediatric patients, renal-transplanted, and hematopoietic stem cell transplanted recipients

Laboratory Medicine

Volumn 41, Issue 10, 2010, Pages 601-606

  Fang, Fengqin ^a   Wang, Xianghui ^a   Hu, Jiong ^a   Zhang, Li ^a   Lu, Ying ^a   Fan, Qishi ^a   Ji, Yuhua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hematopoietic stem cell transplantation; Human cytomegalovirus (HCMV); Renal transplantation; Synonymous polymorphism; UL97 gene

Indexed keywords

GANCICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNITY; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POPULATION RESEARCH; RECIPIENT; SEQUENCE ANALYSIS; UL97 GENE; VIRUS GENE; VIRUS ISOLATION; VIRUS REACTIVATION; VIRUS STRAIN;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 78349258957     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMCPVCAIASKR0MIJ     Document Type: Article

References (16)

1. Fang FQ, Fan QS, Yang ZJ, et al. Incidence of cytomegalovirus infection in Shanghai, China. Clin Vaccine Immunol. 2009;16:1700-1703.
2. Horváth R, Cerný J, Benedík JJ, et al. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol. 2000;16:17-24.
3. Álvarez-Lafuente R, Fernández-Gutiérrez B, de Miguel S, et al. Potential relationship between herpes viruses and rheumatoid arthritis: Analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis. 2005;64:1357-1359.
4. Rawlinson W, Scott G. Cytomegalovirus: A common virus causing serious disease. Aust Fam Physician. 2003;32:789-793.
5. Harari A, Zimmerli SC, Pantaleo G. Cytomegalovirus (CMV)-Specific Cellular Immune Responses. Hum Immunol. 2004;65:500-506.
6. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413-422.
7. von Muller L, Klemm A, Durmus N, et al. Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis. 2007;196:1288-1295.
8. Krosky PM, Baek MC, Coen DM. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol. 2003;77:905-914.
9. Marschall M, Freitag M, Suchy P, et al. The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology. 2003;311:60-71.
10. Wolf DG, Courcelle CT, Prichard MN, et al. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci USA. 2001;98:1895-1900.
11. Gilbert C, Boivin G. Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother. 2005;49:873-883.
12. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315:525-528. (Pubitemid 46175758)
13. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, et al. The sounds of silence: Synonymous mutations affect function. Pharmacogenomics. 2007;8:527-532.
14. Nijhuis M, van Maarseveen NM, Boucher CA. Antiviral resistance and impact on viral replication capacity: Evolution of viruses under antiviral pressure occurs in three phases. Handb Exp Pharmacol. 2009;189:299-320.
15. Buchmann I, Meyer RG, Mier W, et al. Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: Closing the gap between benefit and toxicity? Eur J Nucl Med Mol Imaging. 2009;36:484-498.
16. Zhang M, Gopal AK. Radioimmunotherapy-based conditioning regimens for stem cell transplantation. Semin Hematol. 2008;45:118-125.